My research focuses on investigating the modulation of genetic and epigenetic pathways of cancer development and progression by nutritional interventions, with emphasis on soy isoflavones and lycopene. My expertise is in the area of chemoprevention, nutrition and cancer, particularly in the area of genitourinary cancers with a focus on prostate cancer. I conduct translational research investigating the potential use of natural compounds, including lycopene and soy isoflavones, in the prevention and treatment of cancer. I have conducted the first clinical trials with lycopene and soy isoflavones in prostate cancer patients and discovered that they are potent anti-cancer agents.